Formulation and Method for the Prevention And/Or Treatment of Hangover Symptoms
Phoenix Pharmaceuticals Australia Pty Ltd.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,957,650 | Formulation and Method for the Prevention And/Or Treatment of Hangover Symptoms In force · High confidence UsedRemaining | Phoenix Pharmaceuticals Australia Pty Ltd. | In force | High confidence | ||
| Application 16/087,563 | Formulation and Method for the Prevention And/Or Treatment of Hangover Symptoms Abandoned Abandoned Jun 24, 2021 | Phoenix Pharmaceuticals Australia Pty Ltd. | Abandoned | Abandoned Jun 24, 2021 |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Phoenix Pharmaceuticals Australia Pty Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.